索宝蛋白
(603231)
| 流通市值：16.32亿 | | | 总市值：29.41亿 |
| 流通股本：1.06亿 | | | 总股本：1.91亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 279,055,030.88 | 238,753,582.97 | 159,187,383.97 | 260,620,278.75 |
| 交易性金融资产 | 601,981,386.29 | 655,987,876.26 | 656,335,232.42 | 487,475,277.65 |
| 应收票据及应收账款 | 144,574,558.94 | 146,570,160.06 | 150,305,195.05 | 167,013,472.21 |
| 其中：应收票据 | 5,721,529.78 | 2,889,130.34 | 7,691,570 | 18,829,289.94 |
| 应收账款 | 138,853,029.16 | 143,681,029.72 | 142,613,625.05 | 148,184,182.27 |
| 应收款项融资 | 2,966,594.83 | - | 1,481,072.98 | 325,843.19 |
| 预付款项 | 46,688,336.98 | 26,209,807.11 | 28,992,632.07 | 31,224,780.33 |
| 其他应收款合计 | 19,919,010.89 | 30,742,221.26 | 17,400,693.83 | 4,663,755.43 |
| 存货 | 234,736,116.82 | 241,714,626.1 | 258,977,667.92 | 285,889,553.3 |
| 其他流动资产 | 23,314,835.97 | 20,125,937.59 | 20,426,775.17 | 21,919,921.82 |
| 流动资产合计 | 1,353,235,871.6 | 1,360,104,211.35 | 1,293,106,653.41 | 1,259,132,882.68 |
| 非流动资产: | | | | |
| 长期股权投资 | 9,600,680.33 | 10,067,954.84 | 11,600,505.65 | 12,472,941.69 |
| 固定资产 | 803,771,092.74 | 821,305,236.9 | 765,093,737.6 | 701,993,262.88 |
| 在建工程 | 31,437,663.64 | 12,536,954.27 | 34,234,471.39 | 52,949,854.78 |
| 使用权资产 | 592,175.03 | 664,505.7 | 1,011,961.08 | 468,266.22 |
| 无形资产 | 59,127,913.19 | 59,896,535.21 | 60,300,760.45 | 60,865,258.19 |
| 递延所得税资产 | 3,116,467.63 | 3,181,830.08 | 3,981,382.13 | 3,940,129.52 |
| 其他非流动资产 | 4,736,175.31 | 1,457,180.85 | 4,502,528.17 | 5,529,722.72 |
| 非流动资产合计 | 912,382,167.87 | 909,110,197.85 | 880,725,346.47 | 838,219,436 |
| 资产总计 | 2,265,618,039.47 | 2,269,214,409.2 | 2,173,831,999.88 | 2,097,352,318.68 |
| 流动负债: | | | | |
| 短期借款 | 23,774,000 | 23,774,000 | 23,774,000 | 23,774,000 |
| 应付票据及应付账款 | 152,527,602.3 | 166,435,962.88 | 102,276,771.36 | 84,592,808.96 |
| 其中：应付票据 | 24,500,000 | - | - | - |
| 应付账款 | 128,027,602.3 | 166,435,962.88 | 102,276,771.36 | 84,592,808.96 |
| 合同负债 | 15,202,114.4 | 11,949,793.66 | 12,396,051.49 | 7,554,686.7 |
| 应付职工薪酬 | 9,504,407.34 | 23,609,638.48 | 16,521,754.41 | 15,607,766.57 |
| 应交税费 | 6,468,134.51 | 9,239,327.54 | 14,167,209.47 | 11,674,029 |
| 其他应付款合计 | 2,653,239.91 | 2,035,730.73 | 11,709,059.7 | 2,289,926.32 |
| 一年内到期的非流动负债 | 263,706.33 | 486,079.26 | 706,059.9 | 38,915.09 |
| 其他流动负债 | 7,105,815.97 | 3,963,394.64 | 8,774,119.67 | 17,196,158.1 |
| 流动负债合计 | 217,499,020.76 | 241,493,927.19 | 190,325,026 | 162,728,290.74 |
| 非流动负债: | | | | |
| 递延收益 | 15,469,286.6 | 15,229,481.73 | 13,549,327.48 | 13,752,305.81 |
| 递延所得税负债 | 5,854,682.49 | 5,782,843.65 | 6,267,887.83 | 6,427,232.11 |
| 非流动负债合计 | 21,323,969.09 | 21,012,325.38 | 19,817,215.31 | 20,179,537.92 |
| 负债合计 | 238,822,989.85 | 262,506,252.57 | 210,142,241.31 | 182,907,828.66 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 191,459,105 | 191,459,105 | 191,459,105 | 191,459,105 |
| 资本公积 | 1,237,495,066.7 | 1,237,495,066.7 | 1,237,495,066.7 | 1,237,495,066.7 |
| 其他综合收益 | -5,082.22 | 3,425.71 | 13,481.52 | 23,716.31 |
| 盈余公积 | 52,185,389.52 | 52,185,389.52 | 43,366,961.84 | 43,366,961.84 |
| 未分配利润 | 543,944,062.06 | 525,565,169.7 | 491,355,143.51 | 442,099,640.17 |
| 归属于母公司股东权益合计 | 2,025,078,541.06 | 2,006,708,156.63 | 1,963,689,758.57 | 1,914,444,490.02 |
| 少数股东权益 | 1,716,508.56 | - | - | - |
| 股东权益合计 | 2,026,795,049.62 | 2,006,708,156.63 | 1,963,689,758.57 | 1,914,444,490.02 |
| 负债和股东权益合计 | 2,265,618,039.47 | 2,269,214,409.2 | 2,173,831,999.88 | 2,097,352,318.68 |
| 公告日期 | 2026-04-30 | 2026-04-24 | 2025-10-31 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |